Literature DB >> 27272778

Identification of ESE1 as a β-Catenin Binding Protein.

Xuyu Yang1, Seong-Ho Lee2.   

Abstract

BACKGROUND/AIM: β-Catenin regulates cell-cell adhesion and gene transcription and acts as a master switch that controls proliferation in several types of cancer. ESE1 is an epithelium-restricted transcription factor and its multiple domain structure predicts its interaction with other proteins with diverse cellular functions. Here, for the first time, we report that endogenous β-catenin binds to and co-localizes with endogenous ESE1 in the cytoplasm.
MATERIALS AND METHODS: The binding sites were mapped to E26 transformation-specific (ETS) domain at carboxyl terminus of ESE1 and N-terminus of β-catenin.
RESULTS: We found that C-terminus of ESE1 also binds to α-catenin and that ESE1/β-catenin interaction was abrogated by knockdown of either β-catenin or α-catenin.
CONCLUSION: The data suggest that interactions between ESE1 and β-/α-catenins might be a mechanism by which the ESE1 protein determines the β-catenin function and tumorigenesis. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  ESE1; colon cancer; interaction; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 27272778

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer.

Authors:  Ayumi Takaoka; Toshiaki Ishikawa; Satoshi Okazaki; Shuichi Watanabe; Fuyuki Miya; Tatsuhiko Tsunoda; Akifumi Kikuchi; Shinichi Yamauchi; Takatoshi Matsuyama; Masanori Tokunaga; Hiroyuki Uetake; Yusuke Kinugasa
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 2.  Potential Therapeutic Applications of N-Cadherin Antagonists and Agonists.

Authors:  Orest W Blaschuk
Journal:  Front Cell Dev Biol       Date:  2022-03-03

3.  ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.

Authors:  D Liu; Y Skomorovska; J Song; E Bowler; R Harris; M Ravasz; S Bai; M Ayati; K Tamai; M Koyuturk; X Yuan; Z Wang; Y Wang; R M Ewing
Journal:  Cancer Biol Ther       Date:  2018-08-27       Impact factor: 4.742

Review 4.  ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.

Authors:  Ian Y Luk; Camilla M Reehorst; John M Mariadason
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

5.  ESE1 expression correlates with neuronal apoptosis in the hippocampus after cerebral ischemia/reperfusion injury.

Authors:  Hai-Long Yu; Liang-Zhu Wang; Ling-Ling Zhang; Bei-Lei Chen; Hui-Juan Zhang; Yu-Ping Li; Guo-Dong Xiao; Ying-Zhu Chen
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.